Pharmacological adjuvants for diabetic vitrectomy surgery

Area of Science:

• Ophthalmology
• Retinal Surgery
• Pharmacology

Background:

• Diabetic vitrectomy is a complex procedure for advanced diabetic retinopathy (DR).
• Severe DR manifestations include retinal detachment and vitreous hemorrhage, with variable surgical outcomes.
• Recent advancements in intravitreal pharmacotherapy offer new strategies to enhance surgical results.

Purpose of the Study:

• To review pharmacological adjuncts used in diabetic vitrectomy.
• To analyze their role in facilitating specific surgical steps.
• To categorize adjuncts for improved surgical planning and success.

Main Methods:

• Literature review of pharmacological adjuncts in diabetic vitrectomy.
• Analysis of adjuncts' impact on surgical steps and outcomes.
• Categorization of adjuncts based on their application in the surgical workflow.

Main Results:

• Pharmacological adjuncts can be used before, during, and after diabetic vitrectomy.
• Specific agents can mitigate challenges like bleeding and inflammation.
• Categorization aids surgeons in selecting appropriate adjuncts for specific intraoperative issues.

Conclusions:

• Pharmacological adjuncts are valuable tools in diabetic vitrectomy.
• Strategic use of adjuncts can improve surgical precision and patient outcomes.
• A systematic approach to adjunct selection enhances the management of complex diabetic retinopathy cases.